{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:26:11Z","timestamp":1777451171721,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1124\/jpet.122.001130","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T15:37:13Z","timestamp":1653320233000},"page":"31-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Fate Determination Role of Erythropoietin and Romiplostim in the Lineage Commitment of Hematopoietic Progenitors"],"prefix":"10.1016","volume":"382","author":[{"given":"Xiaoqing","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Krzyzanski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond S.M.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.122.001130_bib1","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1124\/jpet.110.167304","article-title":"Simultaneous pharmacokinetics\/pharmacodynamics modeling of recombinant human erythropoietin upon multiple intravenous dosing in rats","volume":"334","author":"Ait-Oudhia","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001130_bib2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/bdd.712","article-title":"Time-dependent clearance and hematological pharmacodynamics upon erythropoietin multiple dosing in rats","volume":"31","author":"Ait-Oudhia","year":"2010","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/jpet.122.001130_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-226497","article-title":"Use of platelet and erythroid growth factors during induction chemotherapy for acute lymphoblastic leukaemia in a Jehovah\u2019s Witness","volume":"11","author":"Arora","year":"2018","journal-title":"BMJ Case Rep"},{"key":"10.1124\/jpet.122.001130_bib4","series-title":"NONMEM Users Guide Introduction to NONMEM 7.5.0 [Online PDF].","author":"Bauer","year":"2020"},{"key":"10.1124\/jpet.122.001130_bib5","first-page":"541","article-title":"Erythropoietin and platelet production","volume":"84","author":"Beguin","year":"1999","journal-title":"Haematologica"},{"key":"10.1124\/jpet.122.001130_bib6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ajh.2830440406","article-title":"Regulation of megakaryocyte colony forming cell numbers and ploidy by dideoxynucleosides in immunodeficient mice","volume":"44","author":"Chow","year":"1993","journal-title":"Am J Hematol"},{"key":"10.1124\/jpet.122.001130_bib7","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1159\/000142147","article-title":"Neutrophil activation and resistance to recombinant human erythropoietin therapy in hemodialysis patients","volume":"28","author":"Costa","year":"2008","journal-title":"Am J Nephrol"},{"key":"10.1124\/jpet.122.001130_bib8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1902\/jop.1996.67.3.184","article-title":"In vitro comparison of aged and young osteogenic and hemopoietic bone marrow stem cells and their derivative colonies","volume":"67","author":"Dodson","year":"1996","journal-title":"J Periodontol"},{"key":"10.1124\/jpet.122.001130_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007127","article-title":"A novel prospective isolation of murine fetal liver progenitors to study in utero hematopoietic defects","volume":"14","author":"Draper","year":"2018","journal-title":"PLoS Genet"},{"key":"10.1124\/jpet.122.001130_bib10","article-title":"RUNX1B expression is highly heterogeneous and distinguishes megakaryocytic and erythroid lineage fate in adult mouse hematopoiesis","volume":"12","author":"Draper","year":"2016","journal-title":"PLoS Genet"},{"key":"10.1124\/jpet.122.001130_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111838","article-title":"Mimicking hypoxia to treat anemia: HIF-stabilizer BAY 85-3934 (molidustat) stimulates erythropoietin production without hypertensive effects","volume":"9","author":"Flamme","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/jpet.122.001130_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.149","article-title":"Analysis of drug combinations: current methodological landscape","volume":"3","author":"Foucquier","year":"2015","journal-title":"Pharmacol Res Perspect"},{"key":"10.1124\/jpet.122.001130_bib13","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1182\/blood-2012-09-457929","article-title":"CD41 expression marks myeloid-biased adult hematopoietic stem cells and increases with age","volume":"121","author":"Gekas","year":"2013","journal-title":"Blood"},{"key":"10.1124\/jpet.122.001130_bib14","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1084\/jem.148.5.1351","article-title":"Demonstration of Thy-1 antigen on pluripotent hemopoietic stem cells in the rat","volume":"148","author":"Goldschneider","year":"1978","journal-title":"J Exp Med"},{"key":"10.1124\/jpet.122.001130_bib15","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/TA.0000000000000823","article-title":"Mesenchymal stem cells reverse bone marrow dysfunction following injury and stress","volume":"79","author":"Gore","year":"2015","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1124\/jpet.122.001130_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1084\/jem.20131189","article-title":"Erythropoietin guides multipotent hematopoietic progenitor cells toward an erythroid fate","volume":"211","author":"Grover","year":"2014","journal-title":"J Exp Med"},{"key":"10.1124\/jpet.122.001130_bib17","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1182\/blood-2015-09-669929","article-title":"Enhanced thrombopoietin but not G-CSF receptor stimulation induces self-renewing hematopoietic stem cell divisions in vivo","volume":"127","author":"Kovtonyuk","year":"2016","journal-title":"Blood"},{"key":"10.1124\/jpet.122.001130_bib18","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s11095-012-0894-2","article-title":"Pharmacokinetic and pharmacodynamic modeling of romiplostim in animals","volume":"30","author":"Krzyzanski","year":"2013","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.122.001130_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/bjh.12260","article-title":"Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy","volume":"161","author":"Kuter","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1124\/jpet.122.001130_bib20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/MOH.0000000000000625","article-title":"Current understanding of human megakaryocytic-erythroid progenitors and their fate determinants","volume":"28","author":"Kwon","year":"2021","journal-title":"Curr Opin Hematol"},{"key":"10.1124\/jpet.122.001130_bib21","doi-asserted-by":"crossref","first-page":"e562","DOI":"10.1016\/S2352-3026(19)30153-X","article-title":"Romiplostim in patients with refractory aplastic anaemia previously treated with immunosuppressive therapy: a dose-finding and long-term treatment phase 2 trial","volume":"6","author":"Lee","year":"2019","journal-title":"Lancet Haematol"},{"key":"10.1124\/jpet.122.001130_bib22","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1159\/000502525","article-title":"Red blood cell lifespan shortening in patients with early-stage chronic kidney disease","volume":"44","author":"Li","year":"2019","journal-title":"Kidney Blood Press Res"},{"key":"10.1124\/jpet.122.001130_bib23","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/iub.322","article-title":"From stem cell to erythroblast: regulation of red cell production at multiple levels by multiple hormones","volume":"62","author":"Lodish","year":"2010","journal-title":"IUBMB Life"},{"key":"10.1124\/jpet.122.001130_bib24","doi-asserted-by":"crossref","first-page":"24185","DOI":"10.1074\/jbc.M000944200","article-title":"Identification of an erythroid active element in the transferrin receptor gene","volume":"275","author":"Lok","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.122.001130_bib25","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1182\/blood.V93.10.3286.410k29_3286_3293","article-title":"The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply","volume":"93","author":"Loo","year":"1999","journal-title":"Blood"},{"key":"10.1124\/jpet.122.001130_bib26","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/j.celrep.2018.10.084","article-title":"The molecular signature of megakaryocyte-erythroid progenitors reveals a role for the cell cycle in fate specification","volume":"25","author":"Lu","year":"2018","journal-title":"Cell Rep"},{"key":"10.1124\/jpet.122.001130_bib27","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.exphem.2010.06.003","article-title":"Contact with the bone marrow microenvironment readdresses the fate of transplanted hematopoietic stem cells","volume":"38","author":"Massollo","year":"2010","journal-title":"Exp Hematol"},{"key":"10.1124\/jpet.122.001130_bib28","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.exphem.2015.02.004","article-title":"Romiplostim promotes platelet recovery in a mouse model of multicycle chemotherapy-induced thrombocytopenia","volume":"43","author":"McElroy","year":"2015","journal-title":"Exp Hematol"},{"key":"10.1124\/jpet.122.001130_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/5584_2019_455","article-title":"Developments in artificial platelet and erythroid transfusion products","volume":"1247","author":"Meric","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"10.1124\/jpet.122.001130_bib30","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1007\/s00277-015-2485-x","article-title":"Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged \u2265 65 years with immune thrombocytopenia","volume":"94","author":"Michel","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1124\/jpet.122.001130_bib31","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1182\/blood-2016-09-741611","article-title":"Identification of unipotent megakaryocyte progenitors in human hematopoiesis","volume":"129","author":"Miyawaki","year":"2017","journal-title":"Blood"},{"key":"10.1124\/jpet.122.001130_bib32","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.celrep.2018.10.059","article-title":"Thrombopoietin metabolically primes hematopoietic stem cells to megakaryocyte-lineage differentiation","volume":"25","author":"Nakamura-Ishizu","year":"2018","journal-title":"Cell Rep"},{"key":"10.1124\/jpet.122.001130_bib33","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s10928-021-09762-z","article-title":"A quantitative systems pharmacology model of hyporesponsiveness to erythropoietin in rats","volume":"48","author":"Nguyen","year":"2021","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1124\/jpet.122.001130_bib34","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3389\/fphar.2018.00316","article-title":"Dynamics of erythropoietic biomarkers in response to treatment with erythropoietin in Belgrade rats","volume":"9","author":"Nguyen","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1124\/jpet.122.001130_bib35","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/cpt.1434","article-title":"Pharmacodynamic drug-drug interactions","volume":"105","author":"Niu","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.122.001130_bib36","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1634\/stemcells.2007-0899","article-title":"Downregulation of signal transducer and activator of transcription 5 (STAT5) in CD34+ cells promotes megakaryocytic development, whereas activation of STAT5 drives erythropoiesis","volume":"26","author":"Olthof","year":"2008","journal-title":"Stem Cells"},{"key":"10.1124\/jpet.122.001130_bib37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jcyt.2012.11.013","article-title":"Current practices and prospects for standardization of the hematopoietic colony-forming unit assay: a report by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative","volume":"15","author":"Pamphilon","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1124\/jpet.122.001130_bib38","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.exphem.2015.11.010","article-title":"Evolving insights into the synergy between erythropoietin and thrombopoietin and the bipotent erythroid\/megakaryocytic progenitor cell","volume":"44","author":"Papayannopoulou","year":"2016","journal-title":"Exp Hematol"},{"key":"10.1124\/jpet.122.001130_bib39","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2165\/11317190-000000000-00000","article-title":"Pharmacokinetics and pharmacodynamics of the erythropoietin Mimetibody construct CNTO 528 in healthy subjects","volume":"48","author":"P\u00e9rez-Ruixo","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/jpet.122.001130_bib40","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2165\/00003088-200847060-00004","article-title":"Pharmacodynamic analysis of recombinant human erythropoietin effect on reticulocyte production rate and age distribution in healthy subjects","volume":"47","author":"P\u00e9rez-Ruixo","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/jpet.122.001130_bib41","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1182\/blood.V97.2.442","article-title":"Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia","volume":"97","author":"Piron","year":"2001","journal-title":"Blood"},{"key":"10.1124\/jpet.122.001130_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192531","article-title":"A novel approach to adenine-induced chronic kidney disease associated anemia in rodents","volume":"13","author":"Rahman","year":"2018","journal-title":"PLoS One"},{"key":"10.1124\/jpet.122.001130_bib43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1586\/ehm.10.8","article-title":"Current status of thrombopoietic agents","volume":"3","author":"Rhodes","year":"2010","journal-title":"Expert Rev Hematol"},{"key":"10.1124\/jpet.122.001130_bib44","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nm.3814","article-title":"Anemia: progress in molecular mechanisms and therapies","volume":"21","author":"Sankaran","year":"2015","journal-title":"Nat Med"},{"key":"10.1124\/jpet.122.001130_bib45","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1006\/bbrc.2002.6721","article-title":"Expression and function of NJ-1 surface antigen in megakaryopoiesis","volume":"292","author":"Tang","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.122.001130_bib46","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood.V57.1.157.157","article-title":"Cell interactions influencing murine marrow megakaryocytes: nature of the potentiator cell in bone marrow","volume":"57","author":"Williams","year":"1981","journal-title":"Blood"},{"key":"10.1124\/jpet.122.001130_bib47","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1182\/blood-2015-07-607945","article-title":"Hematopoietic stem\/progenitor cell commitment to the megakaryocyte lineage","volume":"127","author":"Woolthuis","year":"2016","journal-title":"Blood"},{"key":"10.1124\/jpet.122.001130_bib48","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0092-8674(95)90234-1","article-title":"Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor","volume":"83","author":"Wu","year":"1995","journal-title":"Cell"},{"key":"10.1124\/jpet.122.001130_bib49","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/stem.2834","article-title":"Concise review: bipotent megakaryocytic-erythroid progenitors: concepts and controversies","volume":"36","author":"Xavier-Ferrucio","year":"2018","journal-title":"Stem Cells"},{"key":"10.1124\/jpet.122.001130_bib50","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s11095-012-0938-7","article-title":"Erythropoietin-induced erythroid precursor pool depletion causes erythropoietin hyporesponsiveness","volume":"30","author":"Yan","year":"2013","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.122.001130_bib51","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1177\/0091270011421911","article-title":"Population pharmacokinetic and pharmacodynamic model-based comparability assessment of a recombinant human epoetin alfa and the biosimilar HX575","volume":"52","author":"Yan","year":"2012","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/jpet.122.001130_bib52","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10928-006-9003-7","article-title":"Assessment of basic indirect pharmacodynamic response models with physiological limits","volume":"33","author":"Yao","year":"2006","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1124\/jpet.122.001130_bib53","doi-asserted-by":"crossref","first-page":"399","DOI":"10.12659\/MSM.890528","article-title":"L-carnosine alters some hemorheologic and lipid peroxidation parameters in nephrectomized rats","volume":"20","author":"Yapislar","year":"2014","journal-title":"Med Sci Monit"},{"key":"10.1124\/jpet.122.001130_bib54","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.exphem.2019.09.021","article-title":"Rats provide a superior model of human stress erythropoiesis","volume":"78","author":"Zhang","year":"2019","journal-title":"Exp Hematol"},{"key":"10.1124\/jpet.122.001130_bib55","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/sctm.17-0057","article-title":"Large-scale ex vivo generation of human red blood cells from cord blood CD34+ cells","volume":"6","author":"Zhang","year":"2017","journal-title":"Stem Cells Transl Med"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524002921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524002921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.122.001130","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T22:07:09Z","timestamp":1743199629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524002921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0022356524002921"],"URL":"https:\/\/doi.org\/10.1124\/jpet.122.001130","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fate Determination Role of Erythropoietin and Romiplostim in the Lineage Commitment of Hematopoietic Progenitors","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.122.001130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}